Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

62706 Press Releases
DateTitleCompany
09 Jan 12 Baxter Submits Application for FDA Approval of GAMMAGARD LIQUID to Treat Multifocal Motor Neuropathy, a Degenerative Neurological Disorder Baxter International Inc.,
Published by
Business Wire
09 Jan 12 Myriant Appoints Susan Hager as Senior Vice President of Corporate Communications and Government Affairs Myriant Corporation,
Published by
Business Wire
09 Jan 12 Biodesix Receives New EU and US Patents for Blood-based Oncology Tests Biodesix Inc.,
Published by
Business Wire
09 Jan 12 Oxford Immunotec Announces that the Centers for Medicare and Medicaid Services (CMS) Increases Reimbursement for the T-SPOT®.TB Test CPT® Code 86481 Oxford Immunotec,
Published by
Business Wire
09 Jan 12 GenturaDx Announces Addition to Board of Directors KIRSHNER COMMUNICATIONS LLC,
Published by
PR Newswire
09 Jan 12 If A Drug Is Legal It Must Be Safe, Right? Wrong. AMERICAN COLLEGE OF EMERGENCY PHYSICIANS,
Published by
PR Newswire
09 Jan 12 PharmMD’s Enhanced Website Provides Branded Imaging, Easier Navigation, Expert MTM Resources and Streaming Media PharmMD,
Published by
Business Wire
09 Jan 12 Cerus Appoints Andrew Gomperts as Chief Business Officer Cerus Corporation,
Published by
Business Wire
09 Jan 12 Genesis Biopharma Appoints Biotech Industry Veteran Hans E. Bishop to Its Board of Directors Genesis Biopharma Inc.,
Published by
Business Wire
09 Jan 12 Tabex Shown to be a Highly Cost Effective Treatment for Smoking Cessation Extab Corporation,
Published by
Business Wire
09 Jan 12 Human Genome Sciences Reports Progress with Commercialization of BENLYSTA® and Announces 2012 Goals at JPMorgan Healthcare Conference Human Genome Sciences Inc.,
Published by
Business Wire
09 Jan 12 Health Net to Sell Medicare Stand-Alone Prescription Drug Plan Business to CVS Caremark for Approximately $160 Million Health Net Inc.,
Published by
Business Wire
09 Jan 12 Health Discovery Corporation Enters into Worldwide Licensing Agreement with NeoGenomics Health Discovery Corporation,
Published by
Business Wire
09 Jan 12 RainDance Technologies Teams with Hospital Saint-Louis and BGI to Confirm Mutations Associated with Rheumatoid Arthritis RainDance Technologies Inc.,
Published by
Business Wire
09 Jan 12 GE Capital Provides $65 Million Asset-Based Credit Facility to Navarro Discount Pharmacy, LLC. GE,
Published by
Business Wire
09 Jan 12 Merck to Present at the 30th Annual J.P. Morgan Healthcare Conference Merck,
Published by
Business Wire
09 Jan 12 Cubist Announces Full Year 2011 Total CUBICIN Net Product Revenues of $735.5 Million, Up 18% Over 2010 Cubist Pharmaceuticals Inc.,
Published by
Business Wire
09 Jan 12 InSite Vision Receives Broad Patent Approval in Japan InSite Vision Incorporated,
Published by
Business Wire
09 Jan 12 OncoMed Pharmaceuticals Promotes Dr. Jakob Dupont to Chief Medical Officer OncoMed Pharmaceuticals Inc.,
Published by
Business Wire
09 Jan 12 Medgenics, Inc. Announces Issue of Options and Restricted Shares to Directors and Officers Medgenics Inc.,
Published by
Business Wire
09 Jan 12 Micromet Signs CRADA with National Cancer Institute to Expand Development of Blinatumomab Micromet Inc.,
Published by
Business Wire
09 Jan 12 Senesco Announces $2.0 Million Equity Financing Senesco Technologies Inc.,
Published by
Business Wire
09 Jan 12 Idera Pharmaceuticals Announces Selection of Toll-like Receptor Agonist Candidates for Evaluation as Vaccine Adjuvants by Merck Idera Pharmaceuticals Inc.,
Published by
Business Wire
09 Jan 12 Clovis Oncology Announces Size of Initial hENT1-Low Population in Pivotal LEAP Trial and Provides Financial Guidance for 2012 Clovis Oncology Inc.,
Published by
Business Wire
09 Jan 12 Progel® Adhesion Barrier Sealant Receives CE Mark Neomend Inc.,
Published by
Business Wire
09 Jan 12 Emergent BioSolutions Provides Preliminary 2011 Financial Results and Provides Guidance for 2012 Emergent BioSolutions Inc.,
Published by
Business Wire
09 Jan 12 New Company, Aerpio Therapeutics, Created to Advance Novel Tie-2 Activators and HIF-1a Stabilizers for Multiple Diseases Aerpio Therapeutics,
Published by
Business Wire
09 Jan 12 Akebia Draws Down $4.1 Million Series B Financing Tranche Akebia Therapeutics Inc.,
Published by
Business Wire
09 Jan 12 Advanced Cell Technology To Present in the Regenerative Medicine Insight Track at the Biotech Showcase™ 2012 in San Francisco Advanced Cell Technology Inc.,
Published by
Business Wire
09 Jan 12 US Interventional Cardiology Device Market Will Shrink by Three Percent Per Year Through 2016 Millennium Research Group,
Published by
Business Wire
Advertising